about
Fingolimod for relapsing-remitting multiple sclerosisAlemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosisRituximab for relapsing-remitting multiple sclerosisRituximab for relapsing-remitting multiple sclerosisNeurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's diseaseUse of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic CountriesPaucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK.Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system.Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in TaiwanPrevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients.Pregnancy in multiple sclerosis: a questionnaire study.Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis.Clinical profile of acute disseminated encephalomyelitis in children.Incidence and prevalence of multiple sclerosis in Europe: a systematic reviewAnti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice.Effectiveness of glatiramer acetate compared to other multiple sclerosis therapiesImpact of Proactive Case Management by Multiple Sclerosis Specialist Nurses on Use of Unscheduled Care and Emergency Presentation in Multiple Sclerosis: A Case Study.Prevalence and incidence of multiple sclerosis in central Poland, 2010-2014T Cell Recruitment in the Brain during Normal Aging.Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancyDepression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.Fatigue, Sleep Quality, and Disability in Relation to Quality of Life in Multiple Sclerosis.Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosisReactivated astrocytes as a possible source of oligodendrocyte precursors for remyelination in remitting phase of experimental autoimmune encephalomyelitis rats.Physical activity in subjects with multiple sclerosis with focus on gender differences: a survey.Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.Multiple sclerosis in Japan appears to be a milder disease compared to the UK.Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.Impact of disease-modifying therapies on the survival of patients with multiple sclerosis in Taiwan, 1997-2008.[Neuro-urological dysfunction of the lower urinary tract in CNS diseases: pathophysiology, epidemiology, and treatment options].Prevalence of multiple sclerosis in Csongrád County, Hungary.Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.Relations between mood characteristics, circadian preferences, and functionality in multiple sclerosis.Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Preinduced With Neurotrophin-3 and Retinoic Acid Into Oligodendrocyte-Like Cells in Demyelinated Spinal Cord of Rats.Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.Using the WHOQOL-DIS to measure quality of life in persons with physical disabilities caused by neurodegenerative disorders.Long-term efficacy and safety of transanal irrigation in multiple sclerosis.
P2860
Q24185882-62F7D6AB-A5DA-4006-9A07-90F602CFA4DBQ24200823-4F93D125-D6DF-42A8-B440-DA9E98612C10Q24234454-CC616A53-A293-42CE-B315-D8F36993FA61Q24234742-6C963B6F-C89E-4CE9-B8A2-7EC3C84C6824Q27012533-472E1E15-4620-4279-8A02-A24D3431B6D0Q27495994-B70839F0-0166-4F77-BFA3-BFA816CDD768Q30387509-B8723CE1-ACA1-494B-B3A7-E0CE1F92E6ECQ30850488-89A26CBC-8121-412C-80B7-8B0AF15C22DFQ31120589-9F065116-0A70-48CD-A1EB-3B4711349ADAQ33712335-B2ED2029-C4E2-4A84-B290-EF067608BED3Q33717231-D567982C-E718-4BFA-97A4-E52CD5F30E00Q33780952-44F31DAC-78DF-4D8E-A5FA-3DB9CED2A94BQ34929788-CEA63D7E-77D7-4EC3-928C-BD5EAD8DB72DQ35000110-968634B3-5D2E-40E5-B382-DA3E730FD20FQ35671468-80F718E8-9E88-492D-B76C-955A7C68D111Q35743570-5177FF83-E498-4499-8510-DEE5541A5DEDQ35974822-F389ECF0-2F3A-4132-BC9D-E59CFB841BF1Q36102286-F294EF46-418B-4596-9CB2-9D4313A4FABBQ36246839-BA2DF3D6-36A9-401C-B223-0252E1D76AABQ36298897-23326B69-E911-4F61-B619-95C38EDAEC44Q36337359-87C82AFB-C9F3-46FE-8984-529148F06E0BQ36358363-A00536E1-86D8-41FD-9771-B5FCFC36D564Q36582315-68FE7DD8-0C11-4E01-9686-C9BDD5BF8667Q37553848-6E500385-0211-4E38-BD48-D33BEB8D976AQ37684368-FB3F5002-32F0-4CD4-88E7-4D4E37AEE5E3Q37997089-CA9993FF-F445-4C1C-AA16-0D4BAFE4F7D8Q41553121-2FF72E0A-E3D3-4C1F-AE55-6D7599752954Q43505644-366C92D9-0A66-4B37-B2DA-BED9D217BBDDQ44146158-004264CB-DD22-462C-AB11-150CAF0C954CQ44788209-C385B106-0C0F-4652-BFC0-B6AF97B054ACQ45729651-F8147558-C48B-4B88-865E-C8025361B931Q47409416-BAECE6B5-D618-4C92-8BB5-5C5E2DAC19ACQ47793211-5FCBA30E-06BB-4B16-A0BF-714CEE10B97DQ47866850-68E8AE5C-4185-4ABD-9737-76372075EE8CQ48313508-8B04327D-2469-4F51-BCF1-030CC9C5AE79Q48736165-F1F760C7-A2D6-4AE6-933D-FB6A1429943FQ50215600-8F5EF763-4D02-4C79-81B9-E9279523993E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiology of multiple sclerosis in Europe: a review.
@en
Epidemiology of multiple sclerosis in Europe: a review.
@nl
type
label
Epidemiology of multiple sclerosis in Europe: a review.
@en
Epidemiology of multiple sclerosis in Europe: a review.
@nl
prefLabel
Epidemiology of multiple sclerosis in Europe: a review.
@en
Epidemiology of multiple sclerosis in Europe: a review.
@nl
P2093
P2860
P1476
Epidemiology of multiple sclerosis in Europe: a review.
@en
P2093
Ephrosyni Koutsouraki
Stavros Baloyannis
Vassiliki Costa
P2860
P356
10.3109/09540261003589216
P577
2010-01-01T00:00:00Z